G. Behre

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
G Behre, G. Behre, G. F. Behre, Gerhard Behre
Publication record
184 papers · 6,637 citations · H-index 40

PAPERS

Characterization of post-vaccination SARS-CoV-2 T cell subtypes in patients with different hematologic malignancies and treatments
20234 citationsauthor #6
Monoclonal Antibody Therapy for COVID-19: A Retrospective Observational Study at a Regional Hospital
20230 citationsauthor #8
PB1768: MICRORNA SIGNATURES IMPLY A ROLE FOR FOXO IN AML CHEMO-RESISTANCE
20230 citationsauthor #4
Bamlanivimab and Etesevimab Improve Symptoms and Associated Outcomes in Ambulatory Patients at Increased Risk for Severe Coronavirus Disease 2019: Results From the Placebo-Controlled Double-Blind Phase 3 BLAZE-1 Trial
20229 citationsauthor #2
P446: USE OF MIRNA EXPRESSION PATTERNS REVEALS ACTIVIN RECEPTOR 2 PATHWAY IN MEDIATING CHEMO-RESISTANT AML
20220 citationsauthor #6
Relationship of micro-RNA, mRNA and eIF Expression in Tamoxifen-Adapted MCF-7 Breast Cancer Cells: Impact of miR-1972 on Gene Expression, Proliferation and Migration
20226 citationsauthor #5
Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome
20227 citationsauthor #4
The tamoxifen-regulated, long non-coding RNA LINC00992 affects proliferation, migration, and expression of tamoxifen resistance-associated genes in MCF-7 breast cancer cells
20221 citationsauthor #3
The impact of G protein-coupled oestrogen receptor 1 on male breast cancer: a retrospective analysis
20211 citationsauthor #9
Monoclonal antibodies therapy for Covid-19 - Experiences at a regional hospital.
20212 citationsauthor #3
Allogeneic stem cell transplantation for mantle cell lymphoma—update of the prospective trials of the East German Study Group Hematology/Oncology (OSHO#60 and #74)
20218 citationsauthor #5
Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible
20203 citationsauthor #10
Allogeneic Hematopoietic Stem Cell Transplantation in a Rare Case of Tonsillar Mast Cell Sarcoma
20205 citationsauthor #9
High expression of the stem cell marker GPR56 at diagnosis identifies acute myeloid leukemia patients at higher relapse risk after allogeneic stem cell transplantation in context with the CD34+/CD38- population.
202011 citationsauthor #10
Pretreatment CD34+/CD38- Cell Burden as Prognostic Factor in Myelodysplastic Syndrome Patients Receiving Allogeneic Stem Cell Transplantation.
20195 citationsauthor #7
Author Correction: Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement
20190 citationsauthor #8
Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement
201917 citationsauthor #8
Comparison of non‐myeloablative and reduced‐intensity allogeneic stem cell transplantation in older patients with myelodysplastic syndromes
201912 citationsauthor #9
Prognostic Impact of Blood MN1 Copy Numbers Before Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia
201921 citationsauthor #12
EVI2B is a C/EBP alpha target gene required for granulocytic differentiation and functionality of hematopoietic progenitors (vol 24, pg 705, 2017)
20190 citationsauthor #13
Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation
20180 citationsauthor #11
Acknowledgement to referees
20180 citationsauthor #91
Prediction of Hepatic Complications after Allogeneic Haemotopoetic Stem Cell Transplantation Using Liver and Spleen Stiffness Measurement
20180 citationsauthor #6
Efficacy and safety of keratinocyte growth factor (palifermin) for prevention of oral mucositis in TBI-based allogeneic hematopoietic stem cell transplantation
20188 citationsauthor #4
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
20180 citationsauthor #11
Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO)
201878 citationsauthor #2
Correction to: EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors
20182 citationsauthor #13
Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients
201862 citationsauthor #12
Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation
201842 citationsauthor #10
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
201819 citationsauthor #11
MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia
201829 citationsauthor #16
Correction to: EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors
20180 citationsauthor #13
Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid Leukemia
20183 citationsauthor #11
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
2017183 citationsauthor #4
Reduction of Immunosuppression after Disease-Specific Donor Cell Chimerism Decrease Can Prevent Hematological Relapse Following Allogeneic Stem Cell Transplantation after Non-Myeloablative (NMA) Conditioning — Results of a Prospective Phase II Study. Eudract #: 2007-002420-15
20170 citationsauthor #8
Declined presentation the novel C/EBPalpha target gene EVI2B regulates myeloid differentiation and hematopoietic progenitor cell function
20170 citationsauthor #13
High BAALC copy numbers in peripheral blood prior to allogeneic transplantation predict early relapse in acute myeloid leukemia patients
201721 citationsauthor #11
Disruption of the C/EBPα—miR-182 balance impairs granulocytic differentiation
20170 citationsauthor #17
The Janus-faced Nature of miR-22 in Hematopoiesis: Is It an Oncogenic Tumor Suppressor or Rather a Tumor-Suppressive Oncogene?
201713 citationsauthor #3
ABR, a novel inducer of transcription factor C/EBPα, contributes to myeloid differentiation and is a favorable prognostic factor in acute myeloid leukemia
201716 citationsauthor #13
Disruption of the C/EBPα—miR-182 balance impairs granulocytic differentiation
201737 citationsauthor #17
Unsupervised hierarchical clustering of surface antigen expression to identify normal karyotype AML patients with distinct disease characteristics and poor outcome.
20170 citationsauthor #14
Prognostic impact of the European LeukemiaNet standardized reporting system in older AML patients receiving stem cell transplantation after non-myeloablative conditioning
201713 citationsauthor #7
Prognostic impact of the CD34+/CD38− cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation
201726 citationsauthor #15
Prognostic Impact of Clonal Hematopoiesis in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission
20171 citationsauthor #11
EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors
201725 citationsauthor #13
Absolute Quantification of Pre-microRNA-155 Copy Numbers By Digital Droplet PCR Identifies Acute Myeloid Leukemia (AML) Patients with Adverse Outcome
20161 citationsauthor #11
Biological Associations and Clinical Impact of Differential Expression of the Pre-Mir-29a/b-1 and Pre-Mir-29b-2/C Clusters in Acute Myeloid Leukemia
20160 citationsauthor #17
High Expression of ZBTB7A at Diagnosis Associated with Inferior Outcome in Acute Myeloid Leukemia Patients Receiving Hematopoietic Stem Cell Transplantation
20160 citationsauthor #12
High Blood BAALC Copy Numbers Determined By Digital Droplet PCR at Timepoint of Allogeneic Transplantation in Complete Remission Predicts Relapse in Patients with Acute Myeloid Leukemia
20160 citationsauthor #12
Next Generation Sequencing and Functional Analysis of Mirna Expression in Acute Myeloid Leukemia Patients with Different FLT3 Mutations: Block of MiR-155 in FLT3-ITD Driven AML Leads to Downregulation of Myeloid Blasts in Vivo
20154 citationsauthor #14
RAR a-RegulatedmiR-181 a / b Cluster Targets the Tumor Suppressor RASSF 1 A in Acute Promyelocytic Leukemia
20150 citationsauthor #13
PML / RAR a-RegulatedmiR-181 a / b Cluster Targets the Tumor Suppressor RASSF 1 A in Acute Promyelocytic Leukemia
20150 citationsauthor #12
Unsupervised Cluster Analysis of Antigen Expression Patterns Identifies Subgroups with Distinct Biological and Clinical Features in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation
20150 citationsauthor #15
Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantation
20156 citationsauthor #7
Assessment of NPM1 Type a Mutation Burden By Digital Droplet PCR As a Marker of Minimal Residual Disease in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation
20150 citationsauthor #12
Prognostic Impact of Aberrant RUNX1 Expression in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
20150 citationsauthor #10
High Expression of the Hedgehog Transcription Factor GLI1 Is Associated with Improved Outcomes in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Non-Myeloablative Conditioning
20150 citationsauthor #12
PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
201544 citationsauthor #11
Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation
201520 citationsauthor #3
Reduced Intensity Conditioning Allogeneic Haematopoietic Stem Cell Transplantation - a Treatment Option in Elderly or Comorbid Patients with Acute Lymphatic Leukemia
20140 citationsauthor #12
CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation
201432 citationsauthor #4
The G-CSF Induced MiR-143 Targets MAPK-Family Proteins and Is a Prognostic Factor for RIC-Transplanted AML Patients
20141 citationsauthor #10
Haploidentical Second Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Acute Leukemia Relapse after First Allo-HSCT: A Retrospective Registry Analysis of 60 Patients on Behalf of the German Cooperative Transplant Group
20141 citationsauthor #6
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma
201428 citationsauthor #25
C/EBPα and MiR-182 Generate a Negative Feedback Loop Which Is Dysregulated in Acute Myeloid Leukemia
20140 citationsauthor #11
The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML‐RARα in APL
201423 citationsauthor #8
High Pri-Mir-181a-1 and Pri-Mir-181a-2 Expression Associates with Improved Outcomes in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning
20140 citationsauthor #16
Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia
20145 citationsauthor #13
Allogeneic stem cell transplantation for mantle cell lymphoma—final report from the prospective trials of the East German Study Group Haematology/Oncology (OSHO)
201452 citationsauthor #5
PML-RARα Repressed Microrna 126 Mediates Differentiation in Acute Promyelocytic Leukemia By Targeting the Protooncogene C-Myb
20140 citationsauthor #10
The PML/RARα-Regulated MiR-181a/b-Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia
20140 citationsauthor #11
Prevention of graft-versus-host-disease with preserved graft-versus-leukemia-effect by ex vivo and in vivo modulation of CD4+ T-cells
201414 citationsauthor #5
Successful Stem Cell Mobilization and Autologous Stem Cell Transplantation after Pretreatment Consisting of Bendamustine, Prednisone and Bortezomib (BPV) in 35 Patients with Newly Diagnosed/Untreated Multiple Myeloma
20140 citationsauthor #21
High Expression of Mir-9 down-Regulates the Poor Outcome Prognosticator ERG and Associates with Reduced Relapse-Rates in Acute Myeloid Leukemia
20143 citationsauthor #16
Prognostic Implications of Pri-Mir-320a Expression in Acute Myeloid Leukemia Patients
20140 citationsauthor #15
Prevention of graft-versus-host-disease with preserved graft-versus-leukemia-effect by ex vivo and in vivo modulation of CD4+ T-cells
20132 citationsauthor #5
Transcription factor C/EBPα-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia.
201339 citationsauthor #11
E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
201333 citationsauthor #6
Prognostic Significance Of EVI1 expression In Acute Myeloid Leukemia Patients With Intermediate and Adverse Cytogenetic Risk Undergoing Allogeneic Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning
20131 citationsauthor #11
E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation
201333 citationsauthor #6
E3 Ubiquitin Ligase E6AP Negatively Regulates Adipogenesis by Downregulating Proadipogenic Factor C/EBPalpha
201322 citationsauthor #6
Proteomic identification of Profilin1 as a corepressor of estrogen receptor alpha in MCF7 breast cancer cells
201317 citationsauthor #8
ABR, a Novel Inducer Of Transcription Factor C/EBPα, Is Necessary For Myeloid Differentiation and a Prognostic Factor In Acute Myeloid Leukemia
20130 citationsauthor #10
The actin‐binding protein CORO1A is a novel PU.1 (SPI1)‐ and CEBPA‐regulated gene with significantly lower expression in APL and CEBPA‐mutated AML patients
20138 citationsauthor #4
Microrna-143 Blocks ERK5 Signaling During Granulocytic Differentiation of Hematopoietic Stem Cells and Is Downregulated in AML
20120 citationsauthor #9
STAT5 and NF-κB Induced Oncogenic Mir-155 Directly Targets PU.1 in FLT3-ITD Associated AML
20120 citationsauthor #10
Proteomic analysis of rosiglitazone and guggulsterone treated 3T3-L1 preadipocytes
201228 citationsauthor #6
C/EBPα-Induced Microrna-30c Directly Targets Notch1 During Granulopoiesis and Is Repressed in Acute Myeloid Leukemia
20120 citationsauthor #11
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study
2012126 citationsauthor #10
Proteomic identification of E6AP as a molecular target of tamoxifen in MCF7 cells
201225 citationsauthor #8
PML/RARα -Regulated MicroRNA 181b Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia
20112 citationsauthor #10
Proteomic approaches in myeloid leukemia
20119 citationsauthor #7
leukemia Heterozygous PU.1 mutations are associated with acute myeloid
20110 citationsauthor #1
Allogeneic Stem Cell Transplantation of Mantle Cell Lymphoma - Results of the Prodpective Trials OSHO #060 and OSHO #074
20111 citationsauthor #5
Comparable Outcome After Single-Antigen Mismatched Versus Matched Unrelated Donor Hematopoietic Cell Transplantation,
20110 citationsauthor #6
Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases.
201197 citationsauthor #6
FLT3-ITD Signaling Induces Oncogenic Mir-155 by NF-κB and STAT5 Pathways In Acute Myeloid Leukemia Thereby Targeting Transcription Factor PU.1,
20111 citationsauthor #8
Kinetics of Engraftment and Predictors of Outcome in Patients with Advanced Chronic Lymphocytic Leukaemia (CLL) After Treatment with Low Dose Total Body Irradiation (TBI) Followed by related or unrelated hematopoietic Stem Cell Transplantation
20110 citationsauthor #10
C/EBPα-Induced MicroRNA 30c Inactivates Notch1 During Granulopoiesis and Is Downregulated In Acute Myeloid Leukemia
20110 citationsauthor #9

TIMELINE

1995 44 citations

1997 0 citations

1998 113 citations

1999 915 citations

2001 1,775 citations

2002 626 citations

2003 513 citations

2004 0 citations

2005 1 citations

2006 150 citations

2007 208 citations

2008 366 citations

2009 68 citations

2010 493 citations

2011 110 citations

2012 179 citations

2013 155 citations

2014 159 citations

2015 74 citations

2016 1 citations

2017 335 citations

2018 243 citations

2019 55 citations

2020 19 citations

2021 11 citations

2022 23 citations

2023 4 citations

G. Behre

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT